Volume & Fat Transfer31 August 2026

The Salmon Sperm Facial Now Has a Cadaver Sequel

Elle reports on Re2O, an injectable derived from human cadaver tissue that has spread through Seoul's clinics on the back of the polynucleotide trend, and links its rise to GLP-1 weight loss. The connection is real: rapid weight loss empties facial fat compartments, and a large market has appeared for anything promising to put volume back without surgery. What these products do not have is the volume. They are skin-quality treatments being pulled toward a structural problem, and the regulatory position on tissue-derived injectables is not what most people assume.

Tagged: GLP-1 · Skin boosters · Regulatory · Marketing claims

Newsletter

The one email a week that isn't selling you something.

What changed in facial rejuvenation this week, one guide we updated, and why it matters. Written by Jay Keni, MD.

A weekly email, once we launch it. We don’t sell or share addresses, and we never add patients from practice records — privacy.